The Muscular Dystrophy Translational Research Program (MDTRP) at Virginia Commonwealth University (VCU) supports and administers research activities for two multicenter networks aimed at developing clinical outcome assessments, resolving variants of unknown significance, and developing biomarkers in the multiple forms of muscular dystrophies. Dr. Nicholas Johnson is the Principal Investigator for these trials and his laboratory is focused on identifying the pathogenesis of myotonic dystrophy, the limb girdle muscular dystrophies, and facioscapulohumeral muscular dystrophy and identifying appropriate clinical endpoints for these conditions.
The MDTRP team supports the core research functions of study coordination, financial oversight, risk management, federal grant administration (pre- and post-award), contract negotiation, feasibility and ethics review, clinical trial tracking and billing integration, regulatory compliance, investigator development and training.
Please visit our careers website linked below to view our open opportunities.
For specific inquiries, please contact Erin DeSpain, Administrative Manager, at email@example.com
To apply for this position or to learn more, please go to https://www.vcujobs.com/
About Virginia Commonwealth University
VCU has been ranked as a top 100 research university based on research expenditures for nine consecutive years by the National Science Foundation and is 65th in research and development expenditures among public research universities. The Carnegie Foundation classifies VCU as an “R1 Doctoral University – Highest Research Activity,” the foundation’s highest ranking. The university also received “Community Engagement” status. This recognition places VCU among an elite class of public research institutions that enjoy both distinctions. VCU remains one of only 25 public institutions to have both a National Cancer Institute-designated cancer center and a clinical and translational science award funded by the National Center for Advancing Translational Sciences.